Bedaquiline fumarate 845533-86-0
5 Inquiries
845533-86-0
SHANGHAI
as reuqired
2024-03-18
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceBedaquiline fumarate is a fumarate salt prepared from equimolar amounts of bedaquiline and fumaric acid. It is used in combination therapy for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria. It has a role as an antitubercular agent and an ATP synthase inhibitor. It contains a bedaquiline(2+).Basic Info
-
Product Name:
Bedaquiline fumarate
Other Name:(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol fumarate;(1R,2S)-1-(6-Bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenyl-2-butanol (2E)-2-butenedioate (1:1);Bedaquiline Fumarate salt;R 403323;(1R,2S)-1-(6-broMo-2-Methoxyquinolin-3-yl)-4-(diMethylaMino)-2-naphthalen-1-yl-1-phenylbutan-2-ol,(E)-but-2-enedioic acid;TMC-207;TMC207;TMC 207;(1R,2S)-1-(6-bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthalenyl)-1-phenyl-2-butanol;R207910 fumarate
CAS No.:845533-86-0
Molecular Formula:C36H35BrN2O6
InChIKeys:ZLVSPMRFRHMMOY-KZDJUSSONA-N
Molecular Weight:671.59
Exact Mass:670.16785
EC Number:605-001-5
UNII:P04QX2C1A5
Color/Form:White to off-white
ATC Code:J04AK05
Categories:
Characteristics-
Critical Temperature & Pressure:
Inert atmosphere,Room Temperature
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
India
BEDAQUILINE FUMARATE
50 KG Feb 8, 2024 
South Korea
cas845533-86-0 Bedaquiline fumarate
1 KG Aug 4, 2026
India
Bedaquiline Fumarate
100 KG Nov 13, 2025
India
BEDAQUILINE FUMARATE
50 KG Apr 28, 2024
India
Bortezomib
100.00 G Jul 30, 2026 Post an enquiry for this product